Skip to main content
. 2024 Oct 17:19322968241289957. Online ahead of print. doi: 10.1177/19322968241289957

Table 3.

CGM-Derived Metrics and Metabolic Data at Third Trimester of Pregnancy in Women Without or With At Least One Adverse Neonatal Outcome.*

Without adverse neonatal outcomes (n = 20) With adverse neonatal outcomes (n = 25) P value
Mean glucose (mg/dL) 107 [92-120] 118 [106-129] .049
Total TAR (>140) (%) 10 [4-23] 26 [12-32] .018
TAR1 (140-180) (%) 9 [4-20] 16 [9-22] .090
TAR2 (>180) (%) 1 [0-4] 6 [2-15] .004
TIR (63-140) (%) 88 [75-92] 71 [64-83] .007
Total TBR (<63) (%) 3 [0.3-6] 1 [0-5] .921
TBR1 (63-54) (%) 2 [0-4] 1 [0-5] .969
TBR2 (<54) (%) 0 [0-1] 0 [0-1] .740
pGRI (%) 18 [10-31] 38 [18-49] .013
GMI (mmol/mol) 40 [37-43] 43 [40-46] .046
CV (%) 24 [20-28] 30 [25-35] .009
TDD/kg (UI/lg) 0.5 [0.2-0.9] 0.8 [0.7-1.2] .070
Weight gain (kg) 10 [8-14] 13 [9-15] .609
HbA1c (%) 5.7 [5.5-6.7] 5.8 [5.5-6.4] .536
*

Among preterm delivery, macrosomia, large for gestational age, small for gestational age, neonatal hypoglycemia, neonatal jaundice, neonatal intensive care unit admission.

Data are expressed as median [interquartile range].

Abbreviations: TAR, time above range; TIR, time in range; TBR, time below range; pGRI, pregnancy-specific Glycemic Risk Index; GMI: glucose management indicator; CV, coefficient of variation; TDD, total daily insulin dose.